[Funding alert] Robotics firm Miko raises Rs 50 Cr from IvyCap, others
Miko said the funding raised will be used for product development and to strengthen global alliances as the company builds a strong global brand.
0 claps
Miko has announced a Rs 50 crore fundraise led by
IvyCap Ventures. The round also saw participation from existing investors like Chiratae Ventures, YourNest Capital, and Keshav Murugesh, Former Chairman of NASSCOM.
The company said the funding raised will be used for product development and to strengthen global alliances as the company builds a strong global brand.
Miko was started in 2015 by IIT Bombay graduates Sneh R Vaswani, Prashant V Iyengar, and Chintan S Raikar, along with global experts in engineering, mathematics, design, and education.
United-states
India
United-kingdom
Bombay
Maharashtra
America
Chintans-raikar
Keshav-murugesh
Vikram-gupta
Sudhir-sethi
Prashantv-iyengar
Snehr-vaswani
Follow us on
FROM TOI PRINT EDITION
Healthcare will never be the same after Covid – given how fast myths were shattered and consumer behaviours transformed April 13, 2021, 8:50 PM IST
By Vikram Gupta, Alka Goel and Malay Krishna
While the Covid pandemic has had a significant negative impact on global health, economy and society, there has been a surprising upside – longstanding practices in the healthcare sector have been transformed, perhaps forever. We outline six common myths that were broken by the pandemic. As we look at the transformations that happened, there is a prescription for building future momentum.
Myth 1: Development of new therapies and vaccines can take years or even decades. Actually, in one year, the world has 12 safe and effective vaccines, with another 20 nearing launches, having entered phase 3 of clinical trials. The speed of pharma discovery began with Chinese researchers sharing the genome of the virus within weeks of the pandemic
China
Vietnam
Republic-of
Bangladesh
India
Nigeria
Pakistan
Chinese
Alka-goel
Vikram-gupta
Malay-krishna
Linkedin